Advertisement
Advertisement
Business /

Investor Relations

Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
Banking & finance

Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates

Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.

IPO

Hong Kong retains IPO crown but may lose to US mega listings over full year

Banking & finance

Chinese company to use AI-powered testing to boost profits and fast-track IVF

videocam
Banking & finance

Insilico Medicine signs AI drug development deal with Eli Lilly

Reaching development, regulatory and commercial milestones could see value of deal hit around US$2.75 billion.

Life Star2, Insilico’s automation lab. Photo: Handout
Life Star2, Insilico’s automation lab. Photo: Handout
Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.

videocam
Banking & finance

HKIC, Gobi Partners and HKU launch fund to back university research start-ups

Gobi-HKU Fund I makes first bets at launch, investing in robotics and AI drug design spin-offs born from university research breakthroughs.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

SFC prepares to inspect Hong Kong IPO listing sponsors amid quality concerns

Market regulator will soon begin inspection of investment banks amid concerns about deficiencies in listing documents and misconduct.

The inspection will focus on whether banks have complied with a circular outlining expectations on staffing and quality controls when handling IPOs, according to the SFC. Photo: Yik Yeung-man
The inspection will focus on whether banks have complied with a circular outlining expectations on staffing and quality controls when handling IPOs, according to the SFC. Photo: Yik Yeung-man
China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

Hong Kong stock market

Hong Kong stocks edge higher as oil steadies, tracking Wall Street gains

Hang Seng Index advances for a second day amid easing concerns over inflation and geopolitical risks.

Banking & finance

Hong Kong attracts wave of biotech IPO filings amid AI drug research boom

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest.

The latest applications come as healthcare and biotechnology equity capital market activity in Hong Kong reached US$15.6 billion last year. Illustration: Shutterstock
Banking & finance

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

Overseas capital tends to cherry-pick a few big-cap pharmaceutical companies rather than buy the biotech sector broadly, according to an analyst. Photo: Handout
Overseas capital tends to cherry-pick a few big-cap pharmaceutical companies rather than buy the biotech sector broadly, according to an analyst. Photo: Handout
IPO

Hong Kong’s IPO pace picks up as 2 mainland Chinese firms get listing approval

Everdisplay Optronics and Galaxis Technology publish post-hearing information packs on the Hong Kong stock exchange.

Insilico

Insilico Medicine advances Middle East push with UAE AI drug discovery deal

Hong Kong-listed biotech firm’s shares jump after announcing partnership to use AI tools in drug discovery in the United Arab Emirates.

Made in China 2025

China biotech outlicensing tops US$52 billion in first 2 months

The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB.

The logo of Sino Biopharmaceutical is seen on a building in Beijing, April 22, 2021. Photo: VCG via Getty Images
IPO

HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings

Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.

Bull statues are seen in front of the Shenzhen Stock Exchange on November 17, 2024. Photo: Getty Images
Bull statues are seen in front of the Shenzhen Stock Exchange on November 17, 2024. Photo: Getty Images
Hong Kong stock market

The big cornerstone comeback: what’s driving investors back to Hong Kong IPOs?

After four subdued years, the cornerstone investors that anchor Hong Kong’s IPO market are returning in force, reshaping the deal landscape.

China stock market

US investors increase buying of Hong Kong, mainland Chinese stocks

American investors bought US$15 billion of Hong Kong and mainland stocks in 2025, as buying picked up steam through the year.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

Hong Kong stocks retreat on AI worries, China markets rally in Year of the Horse

Tech heavyweights drag Hong Kong stocks lower as investors fret over AI disruption following Wall Street’s decline.

All major benchmarks in the US fell overnight over a pessimistic scenario in which advances in AI would disrupt white-collar employment. Photo: Shutterstock
All major benchmarks in the US fell overnight over a pessimistic scenario in which advances in AI would disrupt white-collar employment. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks gain by most in nearly a month on China export optimism

‘China and Hong Kong are the biggest beneficiaries’ of US court decision on tariffs, Goldman Sachs strategists and economists say.

Hong Kong stock market

Hong Kong stocks fall as market reopens after 3-day Lunar New Year holiday

Tech heavyweights Alibaba, Baidu and Kuaishou drop as trading commences in the Year of the Horse.

Hong Kong stock market

Hong Kong stocks rise to wrap up best lunar-year performance in eight years

As market closes for Lunar New Year, benchmark hits 32 per cent gain since the Year of the Snake began in January 2025.

A sign in Central shows Hong Kong stock information on February 6, 2026. Photo: Jonathan Wong
Hong Kong stock market

Korean investors pour US$92.5 million into Hong Kong AI, tech stocks

Return to mainland equities bends towards start-ups and ETFs, versus earlier focus on bellwether, large-cap names.

Bull statues stand near screens showing the Hang Seng Index at Exchange Square in Hong Kong, home of the city’s bourse operator, on February 3, 2026. Photo: Reuters
Bull statues stand near screens showing the Hang Seng Index at Exchange Square in Hong Kong, home of the city’s bourse operator, on February 3, 2026. Photo: Reuters
Hong Kong stock market

Hong Kong stocks slip as regulator summons tech firms over train tickets

Approaching Lunar New Year holiday also dampens investors’ enthusiasm for technology stocks, analyst says.

IPO

Shenzhen-listed Unisplendour abandons plan to raise funds in Hong Kong

The Tsinghua Holdings arm, however, will raise US$800 million via a private share placement on Shenzhen exchange.

Hong Kong stock market

Hong Kong stocks rise as positive holiday bias sets in ahead of Lunar New Year

Southbound net inflows reflect investor optimism about Hong Kong stocks after the holiday, analyst says.

Bull statues look out over Exchange Square, where Hong Kong’s bourse operator is headquartered, on February 3, 2026. Photo: Reuters
Help preserve 120 years of quality journalism.
SUPPORT NOW